Skip to main content
. 2021 Nov 15;21:1227. doi: 10.1186/s12885-021-08943-w

Fig. 1.

Fig. 1

Baseline nomogram, used to predict 1-year and 2-year survival rate in patients with advanced and metastatic pancreatic cancer, created using four independent prognostic factors